91 related articles for article (PubMed ID: 9388502)
1. Estrogens stimulate tamoxifen-induced neuronal cell apoptosis in vitro: a possible nongenomic action.
Hashimoto M; Inoue S; Muramatsu M; Masliah E
Biochem Biophys Res Commun; 1997 Nov; 240(2):464-70. PubMed ID: 9388502
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor beta acts as a dominant regulator of estrogen signaling.
Pettersson K; Delaunay F; Gustafsson JA
Oncogene; 2000 Oct; 19(43):4970-8. PubMed ID: 11042684
[TBL] [Abstract][Full Text] [Related]
3. 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro.
Behl C; Widmann M; Trapp T; Holsboer F
Biochem Biophys Res Commun; 1995 Nov; 216(2):473-82. PubMed ID: 7488136
[TBL] [Abstract][Full Text] [Related]
4. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
[TBL] [Abstract][Full Text] [Related]
5. Effects of 17-beta estradiol and estriol on NMDA-induced toxicity and apoptosis in primary cultures of rat cortical neurons.
Kajta M; Budziszewska B; Marszał M; Lasoń W
J Physiol Pharmacol; 2001 Sep; 52(3):437-46. PubMed ID: 11596861
[TBL] [Abstract][Full Text] [Related]
6. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
Kinoshita Y; Chen S
Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen agonism and estrogen antagonism of c-fos gene promoter activity through non-consensus-responsive elements in MC3T3-E1 osteoblasts.
Ishibashi O; Yamagishi T; Hanada K; Kawashima H
Biochem Biophys Res Commun; 2001 Dec; 289(3):705-11. PubMed ID: 11726205
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
[TBL] [Abstract][Full Text] [Related]
9. Impact of the selective estrogen receptor modulator, tamoxifen, on neuronal outgrowth and survival following toxic insults associated with aging and Alzheimer's disease.
O'Neill K; Chen S; Diaz Brinton R
Exp Neurol; 2004 Aug; 188(2):268-78. PubMed ID: 15246826
[TBL] [Abstract][Full Text] [Related]
10. Hormone-induced apoptosis by Fas-nuclear receptor fusion proteins: novel biological tools for controlling apoptosis in vivo.
Takebayashi H; Oida H; Fujisawa K; Yamaguchi M; Hikida T; Fukumoto M; Narumiya S; Kakizuka A
Cancer Res; 1996 Sep; 56(18):4164-70. PubMed ID: 8797587
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
[TBL] [Abstract][Full Text] [Related]
13. Aryl hydrocarbon receptor-mediated apoptosis of neuronal cells: a possible interaction with estrogen receptor signaling.
Kajta M; Wójtowicz AK; Maćkowiak M; Lasoń W
Neuroscience; 2009 Jan; 158(2):811-22. PubMed ID: 19027052
[TBL] [Abstract][Full Text] [Related]
14. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
15. Regulation of estrogen-mediated cell survival and proliferation by p160 coactivators.
Weldon CB; Elliott S; Zhu Y; Clayton JL; Curiel TJ; Jaffe BM; Burow ME
Surgery; 2004 Aug; 136(2):346-54. PubMed ID: 15300201
[TBL] [Abstract][Full Text] [Related]
16. Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells.
Hui AM; Zhang W; Chen W; Xi D; Purow B; Friedman GC; Fine HA
Cancer Res; 2004 Dec; 64(24):9115-23. PubMed ID: 15604281
[TBL] [Abstract][Full Text] [Related]
17. Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cells.
Seeger H; Wallwiener D; Kraemer E; Mueck AO
Maturitas; 2006 Apr; 54(1):72-7. PubMed ID: 16213115
[TBL] [Abstract][Full Text] [Related]
18. Estradiol protects PC12 cells against CoCl2-induced apoptosis.
Jung JY; Roh KH; Jeong YJ; Kim SH; Lee EJ; Kim MS; Oh WM; Oh HK; Kim WJ
Brain Res Bull; 2008 Aug; 76(6):579-85. PubMed ID: 18598848
[TBL] [Abstract][Full Text] [Related]
19. 17Beta-estradiol abrogates apoptosis in murine skeletal muscle cells through estrogen receptors: role of the phosphatidylinositol 3-kinase/Akt pathway.
Vasconsuelo A; Milanesi L; Boland R
J Endocrinol; 2008 Feb; 196(2):385-97. PubMed ID: 18252962
[TBL] [Abstract][Full Text] [Related]
20. Growth factors prevent changes in Bcl-2 and Bax expression and neuronal apoptosis induced by nitric oxide.
Tamatani M; Ogawa S; Nuñez G; Tohyama M
Cell Death Differ; 1998 Oct; 5(10):911-9. PubMed ID: 10203697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
